Becotatug Vedotin Combined With Pucotenlimab in Platinum- and Immunotherapy-Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma After developing model parameters from the CLL8/10/11 and MURANO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results